StockData
HCW Biologics Inc. logo

HCW Biologics Inc. (HCWB) stock

HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3095% below fair value
$0.76−0.01 (-1.65%)

Close on Nov 18, 2026Market cap $1.40MP/E –Yield –

HCW Biologics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

HCW Biologics's profit margin for the twelve months ending Jun 30, 2026 was -83.8%. For fiscal 2025 it was -14677.1%, against -1169.7% the year before. The highest annual figure on record is -141.5% in fiscal 2020.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-14677.1%−13507.4
FY2024Dec 31, 2024-1169.7%−290.2
FY2023Dec 31, 2023-879.5%−657.9
FY2022Dec 31, 2022-221.7%−80.1
FY2020Dec 31, 2020-141.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-4287.5%+25143.4
Q1 FY2026Mar 31, 202653.4%+43427.1
Q4 FY2025Dec 31, 20252662.8%+3517.3
Q3 FY2025Sep 30, 2025-29183.2%−28268.1
Q2 FY2025Jun 30, 2025-29431.0%−26961.9
Q1 FY2025Mar 31, 2025-43373.6%−42710.8
Q4 FY2024Dec 31, 2024-854.4%−47.7
Q3 FY2024Sep 30, 2024-915.1%−336.2
Q2 FY2024Jun 30, 2024-2469.1%−1778.0
Q1 FY2024Mar 31, 2024-662.8%+11444.0
Q4 FY2023Dec 31, 2023-806.7%−402.8
Q3 FY2023Sep 30, 2023-578.9%−362.5
Q2 FY2023Jun 30, 2023-691.1%+82.1
Q1 FY2023Mar 31, 2023-12106.8%−12040.8
Q4 FY2022Dec 31, 2022-403.9%−454.2
Q3 FY2022Sep 30, 2022-216.4%–
Q2 FY2022Jun 30, 2022-773.3%–
Q1 FY2022Mar 31, 2022-66.0%–
Q4 FY2020Dec 31, 202050.3%–

More HCW Biologics figures

See a number that looks wrong?